ARCHITORG
Archit Organosys financials
- Market cap
- ₹105 Cr
Quarterly results
Q4 FY26: revenue down 15.5%, net profit up 0.0% against the same quarter last year.
| Line item | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 27 | 30 | 26 | 43 | 33 +23% | 33 +11% | 38 +48% | 37 −15% |
| EBITDA | 3 | 3 | 3 | 4 | 4 +36% | 3 −5% | 5 +76% | 5 +11% |
| Net profit | 1 | 1 | 1 | 2 | 2 +102% | 2 +51% | 2 +141% | 2 +0% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +46.0% 1Y
1Y: ₹46.51 on 10 Sept 2025 → ₹67.9. High ₹67.9 (11 Sept 2026), low ₹36.11 (27 Mar 2026).
Financials, as filed
Revenue grew 3.3% a year over 3 years, FY23 to FY26. Operating margin narrowed to 11.6%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹128 Cr | ₹113 Cr | ₹126 Cr | ₹141 Cr |
| Operating profit | ₹19 Cr | ₹6 Cr | ₹13 Cr | ₹16 Cr |
| Operating margin | 14.8% | 5.6% | 10.3% | 11.6% |
| Interest | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| Depreciation | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr |
| Net profit | ₹11 Cr | ₹3 Cr | ₹5 Cr | ₹8 Cr |
| Net margin | 8.9% | 2.9% | 4.0% | 5.7% |
| Cash from operations | ₹17 Cr | ₹10 Cr | — | — |
| Free cash flow | ₹6 Cr | ₹15 Cr | — | — |
| ROCE | 18.0% | 4.0% | — | — |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY07 | FY08 | FY22 | FY23 | FY24 |
|---|---|---|---|---|---|
| Equity capital | ₹3 Cr | ₹3 Cr | ₹21 Cr | ₹21 Cr | ₹21 Cr |
| Reserves | ₹0 Cr | ₹0 Cr | ₹31 Cr | ₹41 Cr | ₹44 Cr |
| Borrowings | ₹4 Cr | ₹7 Cr | ₹34 Cr | ₹31 Cr | ₹26 Cr |
| Other liabilities | ₹3 Cr | ₹3 Cr | ₹18 Cr | ₹27 Cr | ₹18 Cr |
| Total liabilities | ₹10 Cr | ₹13 Cr | ₹104 Cr | ₹120 Cr | ₹108 Cr |
| Fixed assets | ₹3 Cr | ₹3 Cr | ₹45 Cr | ₹50 Cr | ₹60 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹13 Cr | ₹16 Cr | ₹1 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹4 Cr | ₹6 Cr |
| Other assets | ₹7 Cr | ₹10 Cr | ₹44 Cr | ₹50 Cr | ₹42 Cr |
| Total assets | ₹10 Cr | ₹13 Cr | ₹104 Cr | ₹120 Cr | ₹108 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public trimmed −0.50 pp while promoters added +0.49 pp. The shareholder count shrank 10% to 8,959.
- Promoters
- 65.9%
- Public
- 34.1%
Since Jun 2025
- Public −0.50 pp
- Promoters +0.49 pp
How it drifted, 12 quarters
Over this window the public fell from 37.6% to 34.1% — −3.5 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 62.4%, Public 37.6%.Dec '23: Promoters 62.4%, Public 37.6%.Mar '24: Promoters 63.3%, Public 36.7%.Jun '24: Promoters 64.7%, Public 35.4%.Sep '24: Promoters 64.7%, Public 35.4%.Dec '24: Promoters 64.8%, Public 35.1%.Mar '25: Promoters 65.3%, Public 34.7%.Jun '25: Promoters 65.4%, Public 34.6%.Sep '25: Promoters 65.4%, Public 34.6%.Dec '25: Promoters 65.9%, Public 34.1%.Mar '26: Promoters 65.9%, Public 34.1%.Jun '26: Promoters 65.9%, Public 34.1%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Archit Organosys Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Archana Kandarp Amin | 22.53% | unchanged |
| Kandarp Krishnakant Amin | 21.50% | unchanged |
| Suchit Kandarp Amin | 8.68% | unchanged |
| Archit Kandarp Amin | 8.30% | unchanged |
| Shimoli Archit Amin | 2.44% | unchanged |
| Manini Suchit Amin | 2.44% | unchanged |
| Shamoil Plumber | 1.37% | −0.09 pp |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Archit Organosys Limited
Guides on how to read this kind of business and the numbers that matter.